Abstract
Steady state plasma and synovial fluid flurbiprofen concentrations obtained from 26 rheumatoid arthritis patients receiving 100 mg of flurbiprofen b.i.d. were analyzed using the NONMEM program. Only one synovial fluid sample per patient was available. Population estimates for the plasma parameters, clearance, volume of distribution, and elimination half-life were 1.75 L hr−1, 11.9 L, and 4.8 hr, respectively, and the corresponding interindividual variances in these parameters were 29, 19, and 23%, respectively. The apparent elimination half-life from synovial fluid was 7.1 hr. After accounting for interindividual variability there was a residual variability of approximately 40% in both the plasma and synovial fluid concentrations.
Similar content being viewed by others
References
W. J. Wallis and P. A. Simkin. Antirheumatic drug concentrations in human synovial fluid and synovial tissue.Clin. Pharmacokin. 8:496–522 (1983).
S. Wanwimolruk, P. M. Brooks, and D. J. Birkett. Protein binding of non-steroidal antiinflammatory drugs in plasma and synovial fluid of arthritic patients.Br. J. Clin. Pharmacol. 15:91–94 (1983).
T. M. Chalmers, R. C. Glass, and P. C. Risdall. Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: Some preliminary obser vations.Curr. Med. Res. Opinion 5:17–20 (1977).
L. Aarons, R. Salisbury, M. Alam-Siddiqi, L. Taylor, and D. M. Grennan. Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.Br. J. Clin. Pharmacol. 21:155–163 (1986).
S. L. Beal and L. B. Sheiner. Estimating population kinetics.CRC Crit. Rev. Biomed. Eng. 8:195–222 (1982).
R. D. McArthur. Parameter estimation in a two-compartment population pharmacokinetic model with destructive sampling.Math. Biosci. 91:157–173 (1988).
S. L. Beal and L. B. Sheiner.NONMEM Users Guide, University of California, San Francisco, 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aarons, L. The kinetics of flurbiprofen in synovial fluid. Journal of Pharmacokinetics and Biopharmaceutics 19, 265–269 (1991). https://doi.org/10.1007/BF03036250
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03036250